TY  - JOUR
AU  - Majem, Margarita
AU  - Alvarez, Rosa
AU  - Laura Ortega, Ana
AU  - Ruiz de Alda, Lucia
AU  - Gordo, Rocio
AU  - Francisco Garcia, J.
AU  - Ivanova-Markova, Yoana
AU  - Gonzalez-Dominguez, Almudena
AU  - Sanchez San Cristobal, Raquel
AU  - Rojo, Federico
PY  - 2022
DO  - 10.33393/grhta.2022.2449
SN  - 2284-2403
UR  - http://hdl.handle.net/10668/21814
T2  - Global & regional health technology assessment
AB  - Introduction: In recent years, target therapies to specific molecular alterations in advanced non-small cell lung cancer (NSCLC) have been identified and have shown superior efficacy compared to non-targeted treatments. Anaplastic lymphoma kinase...
LA  - en
PB  - Aboutscience srl
KW  - ALK
KW  - Cost -benefit
KW  - Cost-effectiveness
KW  - Economic evaluation
KW  - Lung cancer
KW  - Non-small cell lung cancer
KW  - Care
TI  - Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non-small cell lung cancer in Spain
TY  - research article
VL  - 9
ER  -